Skip to content

Uremic Toxins and Outcomes in Chronic Kidney Disease

The Association Between Uremic Toxins and Outcomes and Comorbidities in Patients With CKD

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03711617
Enrollment
500
Registered
2018-10-18
Start date
2018-05-01
Completion date
2024-12-31
Last updated
2024-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Diseases

Keywords

chronic kidney disease, uremic toxin, prognosis

Brief summary

The aim of this cohort study is: To investigate the etiology and epidemiology of comorbidities in CKD; To find out risk factors associated with the mortality of CKD; To find out uremic toxins which are related to the mortality and comorbidities of CKD; To focuse on the association between uremic toxins and inflammation, oxidative stress and nutritional status in CKD.

Detailed description

To investigate the etiology and epidemiology of comorbidities in CKD; To find out risk factors associated with the mortality of CKD; To find out uremic toxins which are related to the mortality and comorbidities of CKD; To focuse on the association between uremic toxins and inflammation, oxidative stress and nutritional status in CKD.

Interventions

None listed

Sponsors

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* age ≥18 years old; * clinically diagnosed with chronic kidney disease, according K/DOQI criteria.

Exclusion criteria

* acute kidney injury * history of kidney injury \<3 months * malignancy * pregnancy * incomplete clinical data

Design outcomes

Primary

MeasureTime frame
all cause mortality5 years

Secondary

MeasureTime frameDescription
comorbidities5 yearsCVD,mortality,hospitalization

Countries

China

Contacts

Primary ContactFeng Ding, PhD
dingfeng@sjtu.edu.cn86-21-53315165
Backup ContactWenji Wang, MD
wangwj1736@sh9hospital.org86-21-53315165

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026